+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Prostate Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Prostate Cancer Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 217 Pages
  • Global
From
Low-Density Lipoprotein Market - Global Forecast 2025-2030 - Product Thumbnail Image

Low-Density Lipoprotein Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Glioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Glioma Treatment - Global Strategic Business Report

  • Report
  • January 2026
  • 179 Pages
  • Global
From
Glioblastoma Multiforme Treatment Market Forecast to 2033 - Product Thumbnail Image

Glioblastoma Multiforme Treatment Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
From
Malignant Glioma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Malignant Glioma Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 383 Pages
  • Global
From
From
From
From
From
Anti-obesity Drugs Market 2025-2029 - Product Thumbnail Image

Anti-obesity Drugs Market 2025-2029

  • Report
  • March 2025
  • 228 Pages
  • Global
From
Immunomodulators - Global Strategic Business Report - Product Thumbnail Image

Immunomodulators - Global Strategic Business Report

  • Report
  • January 2026
  • 280 Pages
  • Global
From
From
From
From
From
Melanoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Melanoma Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 162 Pages
  • Global
From
Loading Indicator